INOVIO PHARMACEUTICALS INC - NOTE 6.500% 3/0

CUSIP: 45773HAB8

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Debt / NOTE 6.500% 3/0
Market price (% of par)
94.79%
Total 13F principal
$16,415,000
Principal change
$0
Total reported market value
$16,378,000
Number of holders
3

Quarterly Holders Quick Answers

What is CUSIP 45773HAB8?
CUSIP 45773HAB8 identifies 45773HAB8 - INOVIO PHARMACEUTICALS INC - NOTE 6.500% 3/0 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of INOVIO PHARMACEUTICALS INC - NOTE 6.500% 3/0 as of Q1 2022

As of 31 Mar 2022, INOVIO PHARMACEUTICALS INC - NOTE 6.500% 3/0 was held by 3 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $16,415,000 in principal (par value) of the bond. The largest 3 bondholders included WOLVERINE ASSET MANAGEMENT LLC, D. E. Shaw & Co., Inc., and AQR Arbitrage LLC. This page lists 3 institutional bondholders reporting positions for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.